Progenza: Completed Phase I enrollment

Regeneus completed enrollment of 20 patients with Kellgren-Lawrence (KL) grade 2-3 OA of knee in the double-blind, placebo-controlled, dose-escalation, Australian Phase I STEP trial evaluating single ...